Form Bio
Austin, United States · Founded 2022 · $30.0M raised
- Headquarters
- Austin, Texas
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- formbio.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series ASep 2022
- Rounds
- 1
About
AI-driven platform for designing and optimizing genetic medicines and genome engineering for biotech and pharma, improving AAV vector design and genome integrity.
Summary
Form Bio is an Artificial Intelligence company based in Austin, United States, founded in 2022. It has raised $30.0M in total across 1 round, most recently a $30.0M Series A round in Sep 2022. Investors include Jazz Venture Partners, Colossal Biosciences and Tulco.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2022
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.